ICD-10 Code and Management for Hemorrhagic Cerebral Stroke
The ICD-10 code for hemorrhagic cerebral stroke is I61.x for intracerebral hemorrhage, with specific fourth-digit subcategories indicating the location of the hemorrhage within the brain. 1, 2
Diagnostic Coding
The ICD-10 coding system provides specific codes for hemorrhagic stroke:
- I61.0: Intracerebral hemorrhage in hemisphere, subcortical
- I61.1: Intracerebral hemorrhage in hemisphere, cortical
- I61.2: Intracerebral hemorrhage in hemisphere, unspecified
- I61.3: Intracerebral hemorrhage in brain stem
- I61.4: Intracerebral hemorrhage in cerebellum
- I61.5: Intracerebral hemorrhage, intraventricular
- I61.6: Intracerebral hemorrhage, multiple localized
- I61.8: Other intracerebral hemorrhage
- I61.9: Intracerebral hemorrhage, unspecified
The accuracy of these codes is excellent, with positive predictive values of 95.9% for intracerebral hemorrhage 1.
Initial Assessment and Management
Immediate Diagnostic Evaluation
Rapid neuroimaging: CT or MRI should be performed immediately to confirm diagnosis, location, and extent of hemorrhage 3
- CT angiography, MR angiography, or catheter angiography should follow to exclude underlying structural lesions such as aneurysms or arteriovenous malformations 3
Baseline severity assessment:
- NIHSS for awake or drowsy patients
- Glasgow Coma Scale (GCS) for obtunded or comatose patients 3
Laboratory evaluation:
- Coagulation studies (platelet count, PTT, INR)
- Medication history with focus on anticoagulant/antiplatelet use 3
Blood Pressure Management
Acute phase management:
Long-term management:
- BP control should begin immediately after ICH onset and continue long-term 3
Hemostasis Management
For patients on anticoagulants:
- Withhold vitamin K antagonists (VKA)
- Administer therapy to replace vitamin K-dependent factors and correct INR
- Give intravenous vitamin K 3
For patients with severe coagulation factor deficiency or thrombocytopenia:
- Provide appropriate factor replacement therapy or platelets 3
For patients not on antithrombotic drugs:
- Avoid hemostatic therapy 3
Prevention of Secondary Complications
DVT prophylaxis:
Seizure management:
- Treat clinical seizures with antiseizure drugs
- Treat electrographic seizures detected on EEG in patients with altered mental status 3
Glucose management:
- Monitor glucose levels
- Avoid both hyperglycemia and hypoglycemia 3
Dysphagia screening:
- Perform formal screening before initiating oral intake to reduce pneumonia risk 3
Surgical Management
For cerebellar hemorrhage:
- Surgical removal is indicated for patients who are neurologically deteriorating or have brainstem compression and/or hydrocephalus 3
For supratentorial ICH:
Care Setting and Rehabilitation
Initial monitoring and management:
- Should take place in an intensive care unit or dedicated stroke unit with physician and nursing neuroscience acute care expertise 3
Rehabilitation:
- All patients with ICH should have access to multidisciplinary rehabilitation 3
Common Complications to Monitor
Vigilant monitoring for complications is essential as they can worsen outcomes:
- Hematoma expansion (occurs in 30-40% of patients)
- Perihaematomal edema with increased intracranial pressure
- Intraventricular extension with hydrocephalus
- Seizures
- Venous thrombotic events
- Infections 5
Pitfalls to Avoid
Delayed recognition: ICH is a medical emergency with high early deterioration rates; 20% of patients experience a decrease in GCS of ≥2 points between EMS assessment and ED evaluation 3
Inadequate BP control: Achieving BP targets can be challenging and may require aggressive repeated dosing or IV infusion of antihypertensives 3
Missing underlying causes: Failure to identify secondary causes like arteriovenous malformations, tumors, or cerebral amyloid angiopathy 3, 6
Overlooking coagulopathy: Unrecognized or inadequately treated coagulopathy can lead to hematoma expansion 3
Neglecting neurological monitoring: Regular assessment using standardized scales is crucial to detect early deterioration 3